Scotland

Scotland

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.85 (0.72 - 1.04) 2019 Modelled IHME
0.85 (0.71 - 1.01) 2018 Modelled IHME
0.85 (0.70 - 1.01) 2017 Modelled IHME
0.85 (0.72 - 1.01) 2016 Modelled IHME
0.86 (0.73 - 1.03) 2015 Modelled IHME
0.86 (0.73 - 1.02) 2014 Modelled IHME
0.87 (0.73 - 1.03) 2013 Modelled IHME
0.87 (0.73 - 1.03) 2012 Modelled IHME
0.88 (0.72 - 1.05) 2011 Modelled IHME
0.88 (0.71 - 1.06) 2010 Modelled IHME
0.88 (0.72 - 1.06) 2009 Modelled IHME
0.88 (0.73 - 1.04) 2008 Modelled IHME
0.89 (0.74 - 1.04) 2007 Modelled IHME
0.89 (0.75 - 1.05) 2006 Modelled IHME
0.89 (0.75 - 1.05) 2005 Modelled IHME
0.89 (0.75 - 1.05) 2004 Modelled IHME
0.9 (0.75 - 1.06) 2003 Modelled IHME
0.9 (0.75 - 1.07) 2002 Modelled IHME
0.9 (0.75 - 1.08) 2001 Modelled IHME
0.9 (0.74 - 1.09) 2000 Modelled IHME
0.9 (0.74 - 1.09) 1999 Modelled IHME
0.9 (0.74 - 1.09) 1998 Modelled IHME
0.9 (0.74 - 1.08) 1997 Modelled IHME
0.9 (0.73 - 1.09) 1996 Modelled IHME
0.9 (0.73 - 1.09) 1995 Modelled IHME
0.9 (0.73 - 1.08) 1994 Modelled IHME
0.9 (0.74 - 1.09) 1993 Modelled IHME
0.9 (0.74 - 1.09) 1992 Modelled IHME
0.91 (0.74 - 1.10) 1991 Modelled IHME
0.91 (0.74 - 1.11) 1990 Modelled IHME
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.09 (0.06 - 0.13) 2019 Modelled IHME
0.09 (0.06 - 0.13) 2018 Modelled IHME
0.1 (0.06 - 0.14) 2017 Modelled IHME
0.24 (0.17 - 0.32) 2016 Modelled IHME
0.38 (0.27 - 0.51) 2015 Modelled IHME
0.39 (0.28 - 0.52) 2014 Modelled IHME
0.39 (0.27 - 0.53) 2013 Modelled IHME
0.39 (0.28 - 0.54) 2012 Modelled IHME
0.39 (0.27 - 0.55) 2011 Modelled IHME
0.39 (0.27 - 0.56) 2010 Modelled IHME
0.39 (0.27 - 0.56) 2009 Modelled IHME
0.4 (0.26 - 0.57) 2008 Modelled IHME
0.4 (0.26 - 0.57) 2007 Modelled IHME
0.4 (0.25 - 0.58) 2006 Modelled IHME
0.4 (0.24 - 0.58) 2005 Modelled IHME
0.4 (0.25 - 0.58) 2004 Modelled IHME
0.4 (0.26 - 0.57) 2003 Modelled IHME
0.4 (0.26 - 0.57) 2002 Modelled IHME
0.41 (0.27 - 0.57) 2001 Modelled IHME
0.41 (0.28 - 0.58) 2000 Modelled IHME
0.41 (0.28 - 0.57) 1999 Modelled IHME
0.41 (0.27 - 0.56) 1998 Modelled IHME
0.4 (0.27 - 0.56) 1997 Modelled IHME
0.4 (0.26 - 0.56) 1996 Modelled IHME
0.4 (0.26 - 0.57) 1995 Modelled IHME
0.4 (0.26 - 0.57) 1994 Modelled IHME
0.4 (0.26 - 0.58) 1993 Modelled IHME
0.4 (0.26 - 0.58) 1992 Modelled IHME
0.4 (0.25 - 0.60) 1991 Modelled IHME
0.4 (0.25 - 0.61) 1990 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
12 (10 - 15) 2019 Modelled IHME
12 (10 - 15) 2018 Modelled IHME
12 (10 - 15) 2017 Modelled IHME
12 (10 - 15) 2016 Modelled IHME
12 (10 - 15) 2015 Modelled IHME
12 (10 - 15) 2014 Modelled IHME
12 (10 - 15) 2013 Modelled IHME
12 (10 - 15) 2012 Modelled IHME
12 (10 - 15) 2011 Modelled IHME
12 (10 - 15) 2010 Modelled IHME
12 (10 - 15) 2009 Modelled IHME
12 (10 - 15) 2008 Modelled IHME
12 (10 - 15) 2007 Modelled IHME
12 (10 - 15) 2006 Modelled IHME
12 (10 - 15) 2005 Modelled IHME
12 (10 - 15) 2004 Modelled IHME
12 (10 - 15) 2003 Modelled IHME
12 (10 - 15) 2002 Modelled IHME
12 (10 - 15) 2001 Modelled IHME
12 (10 - 15) 2000 Modelled IHME
13 (10 - 15) 1999 Modelled IHME
13 (11 - 15) 1998 Modelled IHME
13 (11 - 15) 1997 Modelled IHME
13 (11 - 16) 1996 Modelled IHME
13 (11 - 16) 1995 Modelled IHME
13 (11 - 16) 1994 Modelled IHME
13 (11 - 16) 1993 Modelled IHME
13 (11 - 16) 1992 Modelled IHME
13 (11 - 16) 1991 Modelled IHME
13 (11 - 16) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
277 (249 - 321) 2015 Survey/reported EMCDDA, 2017
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2024

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.92 (0.75 - 1.13) 2019 Modelled IHME
0.92 (0.75 - 1.12) 2018 Modelled IHME
0.91 (0.74 - 1.13) 2017 Modelled IHME
0.9 (0.74 - 1.11) 2016 Modelled IHME
0.89 (0.73 - 1.10) 2015 Modelled IHME
0.89 (0.72 - 1.09) 2014 Modelled IHME
0.88 (0.72 - 1.08) 2013 Modelled IHME
0.87 (0.71 - 1.08) 2012 Modelled IHME
0.87 (0.71 - 1.08) 2011 Modelled IHME
0.86 (0.69 - 1.08) 2010 Modelled IHME
0.85 (0.69 - 1.06) 2009 Modelled IHME
0.84 (0.67 - 1.04) 2008 Modelled IHME
0.82 (0.66 - 1.02) 2007 Modelled IHME
0.81 (0.65 - 1.01) 2006 Modelled IHME
0.8 (0.64 - 1) 2005 Modelled IHME
0.79 (0.63 - 0.99) 2004 Modelled IHME
0.78 (0.63 - 0.97) 2003 Modelled IHME
0.77 (0.62 - 0.96) 2002 Modelled IHME
0.76 (0.62 - 0.95) 2001 Modelled IHME
0.76 (0.61 - 0.94) 2000 Modelled IHME
0.75 (0.61 - 0.92) 1999 Modelled IHME
0.74 (0.60 - 0.91) 1998 Modelled IHME
0.73 (0.59 - 0.89) 1997 Modelled IHME
0.72 (0.58 - 0.88) 1996 Modelled IHME
0.71 (0.57 - 0.88) 1995 Modelled IHME
0.7 (0.57 - 0.86) 1994 Modelled IHME
0.69 (0.56 - 0.85) 1993 Modelled IHME
0.69 (0.56 - 0.85) 1992 Modelled IHME
0.68 (0.55 - 0.84) 1991 Modelled IHME
0.67 (0.55 - 0.83) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

People who inject drugs (PWID)
Download
Value (%) Year Type Source
52.2 (45.50 - 58.80) 2014 Modelled Degenhardt L et al, 2017

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
37 (33 - 42) 2019 Modelled IHME
38 (34 - 42) 2018 Modelled IHME
38 (34 - 42) 2017 Modelled IHME
38 (34 - 42) 2016 Modelled IHME
38 (34 - 42) 2015 Modelled IHME
38 (34 - 42) 2014 Modelled IHME
38 (34 - 42) 2013 Modelled IHME
38 (34 - 42) 2012 Modelled IHME
38 (34 - 42) 2011 Modelled IHME
37 (33 - 41) 2010 Modelled IHME
37 (33 - 41) 2009 Modelled IHME
37 (33 - 41) 2008 Modelled IHME
37 (33 - 41) 2007 Modelled IHME
37 (33 - 41) 2006 Modelled IHME
37 (33 - 41) 2005 Modelled IHME
37 (33 - 41) 2004 Modelled IHME
37 (33 - 41) 2003 Modelled IHME
37 (33 - 41) 2002 Modelled IHME
37 (33 - 41) 2001 Modelled IHME
37 (33 - 41) 2000 Modelled IHME
37 (33 - 41) 1999 Modelled IHME
37 (33 - 41) 1998 Modelled IHME
37 (33 - 42) 1997 Modelled IHME
37 (33 - 42) 1996 Modelled IHME
37 (33 - 42) 1995 Modelled IHME
37 (33 - 42) 1994 Modelled IHME
37 (33 - 42) 1993 Modelled IHME
37 (33 - 42) 1992 Modelled IHME
37 (33 - 42) 1991 Modelled IHME
37 (33 - 42) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
300 (249 - 321) 2015 Survey/reported EMCDDA, 2017
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2024

Overview

HBV elimination goal
HCV elimination goal
Year of goal
2024

Prevalence (national)

Modelled

HBV (HBsAg+)
0.85 (%)
2019
(0.72 - 1.04(%))
IHME
HCV (RNA/cAg+)
0.92 (%)
2019
(0.75 - 1.13(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
222
2019
(174 - 281)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
409
2019
(341 - 489)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.09 (%)
2019, latest modelled
(0.06 - 0.13(%))
IHME

Prevalence PWID

HCV
52.20 (%)
2014, latest modelled
(45.50 - 58.80(%))
Degenhardt L et al, 2017

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
277
2015
(249 - 321)
EMCDDA, 2017